New Delhi, April 3
The World Health Organisation today said it had suspended the supply of Covaxin, manufactured by India-based Bharat Biotech, through procurement agencies of the United Nations and had asked countries already in receipt of the shot to “take action as appropriate”.
The WHO did not however detail “appropriate action”.
The development implies interruption in Covaxin supply with the production for export suspended for the time being.
In a statement, the global health body said the suspension followed outcomes of its inspection of Bharat Biotech facilities in India as part of the WHO post-emergency use authorisation approval processes. The inspection was held between March 14 and 22.
Bharat Biotech said those who had received Covaxin should not worry as their vaccine certificates were still valid as there was no impact on the efficacy and safety of the vaccine. —
The Tribune News Service brings you the latest news, analysis and insights from the region, India and around the world. Follow the Tribune News Service for a wide-ranging coverage of events as they unfold, with perspective and clarity.
Join Whatsapp Channel of The Tribune for latest updates.
Most Read In 24 Hours
Don't Miss
View All
Top News
As his interim bail ends, Arvind Kejriwal surrenders at Tihar jail
Before surrendering, Kejriwal addresses AAP leaders and work...
Delhi court sends Arvind Kejriwal to judicial custody till June 5
Duty judge Sanjeev Aggarwal passes the order after the chief...
BJP returns to power in Arunachal Pradesh, secures 46 seats in 60-member Assembly
Saffron party had won 41 seats in 2019
Prem Tamang-led SKM sweeps Assembly elections in Sikkim, wins 31 of 32 seats
Opposition Sikkim Democratic Front manages to win one seat
62.8 per cent voter turnout recorded in 13 Lok Sabha constituencies of Punjab
Bathinda records the highest voter turnout of 69.36 per cent
